Eyal Gottlieb

Employment

• The University of Texas MD Anderson Cancer Center Professor
  2023 - Present
• The University of Texas MD Anderson Cancer Center VP, Research
  2023 - Present
• Rappaport Family Institute for Research in the Medical Sciences Director
  2020 - 2022
• Technion Israel Institute of Technology Laura and Isaac Perlmutter Chair of Cancer Research
  2016 - 2022
• Cancer Research UK, Beatson Institute Research Group Leader
  2003 - 2018
• University of Pennsylvania Postdoc; Leukemia and Lymphoma Society Special Fellow
  1999 - 2003
• University of Chicago Postdoc; EMBO Long-Term Fellow
  1998 - 1999

Education

• Technion Israel Institute of Technology MBA
  2018 - 2020
• Weizmann Institute of Science PhD
  1993 - 1998
• Weizmann Institute of Science MSc
  1990 - 1993
• Hebrew University of Jerusalem BSc
  1987 - 1990

Projects & Funding

Projects & funding information is unavailable.

Publications (179)

• A step-by-step guide to performing cancer metabolism research using custom-made media
  Life Science Alliance 2026 DOI: 10.26508/lsa.202503529
  +Save
• A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer
  Radiotherapy and Oncology 2025 DOI: 10.1016/j.radonc.2024.110606
  +Save
• EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer
  EMBO Molecular Medicine 2025 DOI: 10.1038/s44321-025-00240-4
  +Save
• IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures
  Cell Death and Disease 2025 DOI: 10.1038/s41419-025-07838-z
  +Save
• Metabolic Analysis Reveals Methylation Pathways that Mediate Ataxia-Telangiectasia Disorder and Cerebellar-Associated Motor Decline
  Ssrn 2025 DOI: 10.2139/ssrn.5237389
  +Save
• Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions
  Molecular Metabolism 2025 DOI: 10.1016/j.molmet.2025.102192
  +Save
• Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in mice
  Nature Communications 2025 DOI: 10.1038/s41467-025-59310-3
  +Save
• Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer
  Cancer Research 2025 DOI: 10.1158/0008-5472.CAN-25-0654
  +Save
• Metabolic alterations and cellular responses to β-Hydroxybutyrate treatment in breast cancer cells.
  Cancer & metabolism 2024 DOI: 10.1186/s40170-024-00339-1
  +Save
• Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD.
  Cell metabolism 2024 DOI: 10.1016/j.cmet.2023.12.013
  +Save